|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu SV and Giaccone G: Lung cancer in
2013: Refining standard practice and admitting uncertainty. Nat Rev
Clin Oncol. 11:69–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song X, Zhao C, Jiang L, Lin S, Bi J, Wei
Q, Yu L, Zhao L and Wei M: High PITX1 expression in lung
adenocarcinoma patients is associated with DNA methylation and poor
prognosis. Pathol Res Pract. 214:2046–2053. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Rong X, Chen Y and Su L:
Methylation-mediated loss of SFRP2 enhances invasiveness of
non-small cell lung cancer cells. Hum Exp Toxicol. 37:155–162.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Wang Y, Liu F, Xu L, Peng F, Zhao
N, Fu B, Zhu Z, Shi Y, Liu J, et al: A systematic review and
meta-analysis: Association between MGMT hypermethylation and the
clinicopathological characteristics of non-small-cell lung
carcinoma. Sci Rep. 8:14392018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raungrut P, Petjaroen P, Geater SL,
Keeratichananont W, Phukaoloun M, Suwiwat S and Thongsuksai P:
Methylation of 14-3-3s gene and prognostic significance of 14-3-3s
expression in non-small cell lung cancer. Oncol Lett. 14:5257–5264.
2017.PubMed/NCBI
|
|
7
|
Zhou Y, Qiu XP, Li ZH, Zhang S, Rong Y,
Yang GH and Fang-Zheng: Clinical significance of aberrant
cyclin-dependent kinase-like 2 methylation in hepatocellular
carcinoma. Gene. 683:35–40. 2019. View Article : Google Scholar
|
|
8
|
Peters I, Dubrowinskaja N, Hennenlotter J,
Antonopoulos WI, Von Klot CAJ, Tezval H, Stenzl A, Kuczyk MA and
Serth J: DNA methylation of neural EGFL like 1 (NELL1) is
associated with advanced disease and the metastatic state of renal
cell cancer patients. Oncol Rep. 40:3861–3868. 2018.PubMed/NCBI
|
|
9
|
Li F, Xue ZY, Yuan Y, Huang SS, Fan YH,
Zhu X and Wei L: Upregulation of CXCR4 through promoter
demethylation contributes to inflammatory hyperalgesia in rats. CNS
Neurosci Ther. 24:947–956. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang C, Guo J, Cheng H and Feng YH:
Induced expression of endogenous CXCR4 in iPSCs by targeted CpG
demethylation enhances cell migration toward the ligand CXCL12.
Inflammation. 42:20–34. 2019. View Article : Google Scholar
|
|
11
|
Kang D and Hamasaki N: Mitochondrial
oxidative stress and mitochondrial DNA. Clin Chem Lab Med.
41:1281–1288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nogueira V and Hay N: Molecular pathways:
Reactive oxygen species homeostasis in cancer cells and
implications for cancer therapy. Clin Cancer Res. 19:4309–4314.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin S, Li Y, Zamyatnin AA Jr, Werner J and
Bazhin AV: Reactive oxygen species and colorectal cancer. J Cell
Physiol. 233:5119–5132. 2018. View Article : Google Scholar
|
|
14
|
Knoops B, Goemaere J, Van der Eecken V and
Declercq JP: Peroxiredoxin 5: Structure, mechanism, and function of
the mammalian atypical 2-Cys peroxiredoxin. Antioxid Redox Signal.
15:817–829. 2011. View Article : Google Scholar
|
|
15
|
Kim B, Park J, Chang KT and Lee DS:
Peroxiredoxin 5 prevents amyloid-beta oligomer-induced neuronal
cell death by inhibiting ERK-Drp1-mediated mitochondrial
fragmentation. Free Radic Biol Med. 90:184–194. 2016. View Article : Google Scholar
|
|
16
|
Kim B, Kim YS, Ahn HM, Lee HJ, Jung MK,
Jeong HY, Choi DK, Lee JH, Lee SR, Kim JM and Lee DS: Peroxiredoxin
5 overexpression enhances tumorigenicity and correlates with poor
prognosis in gastric cancer. Int J Oncol. 51:298–306. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Byun JM, Kim SS, Kim KT, Kang MS, Jeong
DH, Lee DS, Jung EJ, Kim YN, Han J, Song IS, et al: Overexpression
of peroxiredoxin-3 and -5 is a potential biomarker for prognosis in
endometrial cancer. Oncol Lett. 15:5111–5118. 2018.PubMed/NCBI
|
|
18
|
Baumann C, Bonilla WV, Fröhlich A,
Helmstetter C, Peine M, Hegazy AN, Pinschewer DD and Löhning M:
T-bet- and STAT4-dependent IL-33 receptor expression directly
promotes antiviral Th1 cell responses. Proc Natl Acad Sci USA.
112:4056–4061. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koch MA, Thomas KR, Perdue NR, Smigiel KS,
Srivastava S and Campbell DJ: T-bet(+) Treg cells undergo abortive
Th1 cell differentiation due to impaired expression of IL-12
receptor β2. Immunity. 37:501–510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Akira S, Nishio Y, Inoue M, Wang XJ, Wei
S, Matsusaka T, Yoshida K, Sudo T, Naruto M and Kishimoto T:
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3
p91-related transcription factor involved in the gp130-mediated
signaling pathway. Cell. 77:63–71. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang LH, Hao YL and Zhu JW: Expression
and prognostic value of HER-2/neu, STAT3 and SOCS3 in
hepatocellular carcinoma. Clin Res Hepatol Gastroenterol.
43:282–291. 2019. View Article : Google Scholar
|
|
22
|
Fathi N, Rashidi G, Khodadadi A, Shahi S
and Sharifi S: STAT3 and apoptosis challenges in cancer. Int J Biol
Macromol. 117:993–1001. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chu Y, Wang Y, Peng W, Xu L, Liu M, Li J,
Hu X, Li Y, Zuo J and Ye Y: STAT3 activation by IL-6 from
adipose-derived stem cells promotes endometrial carcinoma
proliferation and metastasis. Biochem Biophys Res Commun.
500:626–631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Raju S, Joseph R and Sehgal S: Review of
checkpoint immunotherapy for the management of non-small cell lung
cancer. Immunotargets Ther. 7:63–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sabharwal SS, Waypa GB, Marks JD and
Schumacker PT: Peroxiredoxin-5 targeted to the mitochondrial
intermembrane space attenuates hypoxia-induced reactive oxygen
species signal-ling. Biochem J. 456:337–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan Y, Liu G, Zhou F, Su B and Li Y: DNA
methylation profiles in cancer diagnosis and therapeutics. Clin Exp
Med. 18:1–14. 2018. View Article : Google Scholar
|
|
28
|
Zhang HH, Hu J, Zhou YL, Qin X, Song ZY,
Yang PP, Hu S, Jiang X and Xu GY: Promoted interaction of nuclear
factor-kB with demethylated purinergic P2X3 receptor gene
contributes to neuropathic pain in rats with diabetes. Diabetes.
64:4272–4284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou YL, Jiang GQ, Wei J, Zhang HH, Chen
W, Zhu H, Hu S, Jiang X and Xu GY: Enhanced binding capability of
nuclear factor-kB with demethylated P2X3 receptor gene contributes
to cancer pain in rats. Pain. 156:1892–1905. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi HI, Ma SK, Bae EH, Lee JU and Kim SW:
Peroxiredoxin 5 protects TGF-β induced fibrosis by inhibiting stat3
activation in rat kidney interstitial fibroblast cells. PLoS One.
11:e01492662016. View Article : Google Scholar
|
|
31
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Acloque H, Ocaña OH, Matheu A, Rizzoti K,
Wise C, Lovell-Badge R and Nieto MA: Reciprocal repression between
Sox3 and snail transcription factors defines embryonic territories
at gastrulation. Dev Cell. 21:546–558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Correa-Costa M, Andrade-Oliveira V, Braga
TT, Castoldi A, Aguiar CF, Origassa CST, Rodas ACD, Hiyane MI,
Malheiros DMAC, Rios FJO, et al: Activation of platelet- activating
factor receptor exacerbates renal inflammation and promotes
fibrosis. Lab Invest. 94:455–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruscetti M, Quach B, Dadashian EL,
Mulholland DJ and Wu H: Tracking and functional characterization of
epithelial-mesen-chymal transition and mesenchymal tumor cells
during prostate cancer metastasis. Cancer Res. 75:2749–2759. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grande MT, Sanchez-Laorden B, Lopez-Blau
C, De Frutos CA, Boutet A, Arévalo M, Rowe RG, Weiss SJ,
López-Novoa JM and Nieto MA: Snail1-induced partial
epithelial-to-mesenchymal transition drives renal fibrosis in mice
and can be targeted to reverse established disease. Nat Med.
21:989–997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ahn HM, Yoo JW, Lee S, Lee HJ, Lee HS and
Lee DS: Peroxiredoxin 5 promotes the epithelial-mesenchymal
transition in colon cancer. Biochem Biophys Res Commun.
487:580–586. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stewart D, Killeen E, Naquin R, Alam S and
Alam J: Degradation of transcription factor Nrf2 via the
ubiquitin-proteasome pathway and stabilization by cadmium. J Biol
Chem. 278:2396–2402. 2003. View Article : Google Scholar
|
|
38
|
Nguyen T, Sherratt PJ, Huang HC, Yang CS
and Pickett CB: Increased protein stability as a mechanism that
enhances Nrf2-mediated transcriptional activation of the
antioxidant response element. Degradation of Nrf2 by the 26 S
proteasome. J Biol Chem. 278:4536–4541. 2003. View Article : Google Scholar
|
